These results suggest that while 10% TNJ treatment impeded growth of the mammary tumors, it did not prevent metastatic progression to the lungs in the MMTV-neu mice, despite less vascular invasion within the mammary tumors (Table 1). The gene discussed is ERBB2; the disease is breast cancer.